TAMOXIFEN AND CONTRALATERAL BREAST CANCER-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TAMOXIFEN AND CONTRALATERAL BREAST CANCER

Published:1985-08 Issue:8449 Volume:326 Page:282
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Cuzick J.,Baum M.

Publisher

Elsevier BV

Subject

General Medicine

Reference1 articles.

1. Bilateral primary breast cancer a prospective study of disease incidence;Chaudary;Br J Surg,1984

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The antipsychotic drug pimozide promotes apoptosis through the RAF/ERK pathway and enhances autophagy in breast cancer cells;Cancer Biology & Therapy;2024-02-14

2. Leveraging GWAS: Path to Prevention?;Cancer Prevention Research;2024-01-04

3. Genotypic variations of the CYP2D6 gene in patients with breast cancer treated with tamoxifen: case series;European Journal of Oncology Pharmacy;2023-07

4. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms;Frontiers in Pharmacology;2023-04-19

5. Tamoxifen evolution;British Journal of Cancer;2023-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP